Annual SG&A
$31.10 M
+$5.96 M+23.73%
31 December 2023
Summary:
Aclaris Therapeutics annual selling, general & administrative expenses is currently $31.10 million, with the most recent change of +$5.96 million (+23.73%) on 31 December 2023. During the last 3 years, it has risen by +$10.57 million (+51.48%). ACRS annual SG&A is now at all-time high.ACRS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.65 M
+$901.00 K+18.96%
30 September 2024
Summary:
Aclaris Therapeutics quarterly selling, general & administrative expenses is currently $5.65 million, with the most recent change of +$901.00 thousand (+18.96%) on 30 September 2024. Over the past year, it has dropped by -$1.15 million (-16.84%). ACRS quarterly SG&A is now -70.23% below its all-time high of $18.99 million, reached on 30 June 2018.ACRS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.16 B
-$37.00 M-1.18%
30 September 2024
Summary:
Aclaris Therapeutics TTM selling, general & administrative expenses is currently -$3.16 billion, with the most recent change of -$37.00 million (-1.18%) on 30 September 2024. Over the past year, it has dropped by -$3.19 billion (-10634.68%). ACRS TTM SG&A is now -15146.83% below its all-time high of $49.38 million, reached on 31 December 2018.ACRS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.7% | -16.8% | -10000.0% |
| 3 y3 years | +51.5% | -5.5% | -10000.0% |
| 5 y5 years | +20.7% | -17.3% | -10000.0% |
ACRS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +51.5% | -35.7% | +19.0% | -46.3% | at low |
| 5 y | 5 years | at high | +51.5% | -35.7% | +46.5% | -120.2% | at low |
| alltime | all time | at high | +1657.9% | -70.2% | +458.2% | <-9999.0% | at low |
Aclaris Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.65 M(+19.0%) | $25.46 M(-4.3%) |
| June 2024 | - | $4.75 M(-30.6%) | $26.61 M(-8.7%) |
| Mar 2024 | - | $6.84 M(-16.7%) | $29.15 M(-6.3%) |
| Dec 2023 | $31.10 M(+23.7%) | $8.21 M(+20.8%) | $31.10 M(+3.6%) |
| Sept 2023 | - | $6.80 M(-6.8%) | $30.03 M(+3.4%) |
| June 2023 | - | $7.30 M(-17.0%) | $29.05 M(+4.4%) |
| Mar 2023 | - | $8.79 M(+23.0%) | $27.82 M(+10.7%) |
| Dec 2022 | $25.13 M(+6.4%) | $7.15 M(+22.9%) | $25.13 M(+0.8%) |
| Sept 2022 | - | $5.81 M(-4.3%) | $24.93 M(-0.7%) |
| June 2022 | - | $6.08 M(-0.4%) | $25.10 M(+0.8%) |
| Mar 2022 | - | $6.10 M(-12.2%) | $24.89 M(+5.4%) |
| Dec 2021 | $23.62 M(+15.0%) | $6.94 M(+16.1%) | $23.62 M(+9.5%) |
| Sept 2021 | - | $5.98 M(+1.9%) | $21.57 M(+10.9%) |
| June 2021 | - | $5.87 M(+21.6%) | $19.45 M(+1.6%) |
| Mar 2021 | - | $4.83 M(-1.4%) | $19.16 M(-6.7%) |
| Dec 2020 | $20.53 M(-26.2%) | $4.90 M(+26.9%) | $20.53 M(-5.3%) |
| Sept 2020 | - | $3.86 M(-30.7%) | $21.69 M(-12.1%) |
| June 2020 | - | $5.57 M(-10.1%) | $24.67 M(-7.1%) |
| Mar 2020 | - | $6.20 M(+2.4%) | $26.56 M(-4.5%) |
| Dec 2019 | $27.83 M | $6.06 M(-11.4%) | $27.83 M(-2.2%) |
| Sept 2019 | - | $6.84 M(-8.4%) | $28.46 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $7.47 M(+0.1%) | $27.83 M(-29.3%) |
| Mar 2019 | - | $7.46 M(+11.6%) | $39.35 M(-20.3%) |
| Dec 2018 | $25.76 M(+42.9%) | $6.69 M(+7.8%) | $49.38 M(+20.1%) |
| Sept 2018 | - | $6.20 M(-67.3%) | $41.11 M(-4.5%) |
| June 2018 | - | $18.99 M(+8.6%) | $43.03 M(+41.7%) |
| Mar 2018 | - | $17.49 M(-1208.6%) | $30.37 M(+68.4%) |
| Dec 2017 | $18.03 M(+21.9%) | -$1.58 M(-119.4%) | $18.03 M(-24.8%) |
| Sept 2017 | - | $8.12 M(+28.3%) | $24.00 M(+22.9%) |
| June 2017 | - | $6.33 M(+22.7%) | $19.52 M(+19.4%) |
| Mar 2017 | - | $5.16 M(+17.7%) | $16.34 M(+10.5%) |
| Dec 2016 | $14.79 M(+177.6%) | $4.38 M(+20.1%) | $14.79 M(+15.5%) |
| Sept 2016 | - | $3.65 M(+15.8%) | $12.81 M(+23.3%) |
| June 2016 | - | $3.15 M(-12.5%) | $10.39 M(+29.2%) |
| Mar 2016 | - | $3.60 M(+50.2%) | $8.04 M(+50.9%) |
| Dec 2015 | $5.33 M(+163.0%) | $2.40 M(+94.6%) | $5.33 M(+53.3%) |
| Sept 2015 | - | $1.23 M(+53.5%) | $3.48 M(+23.8%) |
| June 2015 | - | $803.00 K(-10.0%) | $2.81 M(+40.0%) |
| Mar 2015 | - | $892.00 K(+62.8%) | $2.00 M(+80.1%) |
| Dec 2014 | $2.03 M(+14.5%) | $548.00 K(-3.0%) | $1.11 M(+97.0%) |
| Sept 2014 | - | $565.00 K | $565.00 K |
| Dec 2013 | $1.77 M | - | - |
FAQ
- What is Aclaris Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual SG&A year-on-year change?
- What is Aclaris Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly SG&A year-on-year change?
- What is Aclaris Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM SG&A year-on-year change?
What is Aclaris Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of ACRS is $31.10 M
What is the all time high annual SG&A for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual selling, general & administrative expenses is $31.10 M
What is Aclaris Therapeutics annual SG&A year-on-year change?
Over the past year, ACRS annual selling, general & administrative expenses has changed by +$5.96 M (+23.73%)
What is Aclaris Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ACRS is $5.65 M
What is the all time high quarterly SG&A for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly selling, general & administrative expenses is $18.99 M
What is Aclaris Therapeutics quarterly SG&A year-on-year change?
Over the past year, ACRS quarterly selling, general & administrative expenses has changed by -$1.15 M (-16.84%)
What is Aclaris Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ACRS is -$3.16 B
What is the all time high TTM SG&A for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM selling, general & administrative expenses is $49.38 M
What is Aclaris Therapeutics TTM SG&A year-on-year change?
Over the past year, ACRS TTM selling, general & administrative expenses has changed by -$3.19 B (-10634.68%)